One more top-tier global pharma selects ACCURIDS for EMA PMS readiness

We're excited to welcome another leading global pharma company that has selected ACCURIDS for its EMA PMS alignment program: a healthcare leader with a portfolio spanning 1,000+ molecules across generics and established brands, reaching patients in 165+ countries.

‍

With a portfolio that size, product data ends up scattered across systems. EMA PMS requires submitting IDMP-compliant medicinal product data. But the data companies hold in their RIM rarely maps cleanly to EMA's model. Our customer chose a different approach: a non-invasive, IDMP-native standardization fabric that connects to their existing RIM and authoritative sources, transforms that data into the Pistoia Alliance IDMP-Ontology, which we co-developed, and unifies it into audit-ready Golden Records ready for EMA PMS submission.

‍

What we're building together: a Product Data Backbone that is, by design:

→ Independent of systems – no replacements, no force-fit.

→ Ready for regulation – aligned with EMA PMS requirements.

→ Ready for AI – clean, structured, semantically consistent.

‍

We're proud to partner with the world's leading pharma companies,and grateful to our customers, including this latest addition, for trusting us with their EMA PMS journey. Wins like this reflect a broader shift: with EMA PMS on the horizon, more pharma organizations are putting IDMP-compliant product data foundations in place now – turning a regulatory obligation into audit-ready, AI-ready product data.

‍

Trusted by 9 of the world's top pharma companies. 

‍

If EMA PMS is on your roadmap, download our strategic playbook for regulatory leaders: 
‍Navigating EMA PMS Requirements

‍